A Study Of Epidemiology, Mechanistic Pathways, And Outcomes Of Propofol-Associated Hypertriglyceridemia

Overview

About this study

The purpose of this study is to define the true epidemiology, mechanistic pathways, and causal relationships of propofol-associated hypertriglyceridemia through the first prospective observational cohort with systematic triglyceride monitoring.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥18 years

  • Admitted to an adult ICU at Mayo Clinic Rochester

  • Currently on mechanical ventilation receiving continuous propofol infusion

  • Has been on mechanical ventilation with propofol for at least 24 hours

  • The clinical team expects the patient to remain intubated

  • No active plans for transition to comfort care measures

  • Legally authorized representative available for consenting (if patient lacks decision-making capacity)

Exclusion Criteria:

  • Transfer from an outside hospital where propofol was already being administered at the time of ICU admission (rationale: unable to obtain baseline pre-propofol triglyceride level from stored pre-intubation specimens)

  • Anticipated extubation within 24 hours of screening (rationale: insufficient time to observe P-HTG development and resolution patterns)

  • Patient or LAR declines participation

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 04/06/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Hemang Yadav, M.B.B.S.

Contact us for the latest status

More information

Publications

Publications are currently not available
.
CLS-20602059

Mayo Clinic Footer